Drawing for CYNAPSUS

USPTO serial 87078707

CYNAPSUS

Reviewed by CopyMark Law Group

Status 606
Filing date
Status date
Registration date
Examiner
EULIN, INGRID C
Law office
INTENT TO USE SECTION

What this means

This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.

Need help with CYNAPSUS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Jeffrey R. Cadwell

Jeffrey R. Cadwell Dorsey & Whitney LLP50 South Sixth Street, Suite 1500Minneapolis, MN 55402-1498UNITED STATES

Goods and services

ClassDescriptionStatusFirst use
005Sublingual thin filmstrip of apomorphine to treat Parkinson's Disease OFF hypomobility episodes; pharmaceutical preparations for the treatment of Parkinson's Disease OFF hypomobility episodes, delivered orally via a sublingual thin filmstrip; therapeutic preparations to manage Parkinson's Disease OFF hypomobility episodes, delivered orally via a sublingual thin filmstrip; pharmaceutical preparations for the treatment of Parkinson's Disease; therapeutic pharmaceutical preparations for the treatment of Parkinson's Disease; pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system movement disorders and infections, and brain diseases; therapeutic pharmaceutical preparations for the treatment of the central nervous system, namely central nervous system movement disorders and infections, and brain diseases; pharmaceutical preparations acting on the central nervous system; therapeutic pharmaceutical preparations acting on the central nervous system; drug delivery agents in the form of sublingual filmstrips to facilitate delivery of a wide range of prescription pharmaceuticals by providing release of active ingredientsACTIVE
042Research and development of medicines and vaccines in the field of central nervous system pharmaceuticals; pharmaceutical research and development; research and development of medicinesACTIVE
044Providing information regarding Parkinson's disease and Parkinson's disease OFF hypomobility episodes; providing information in the field of central nervous system disorders, infections, and diseasesACTIVE

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

Latest event (MAB6): The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.

DateCodeEventWhat it means
Jan 2, 2024MAB6ABANDONMENT NOTICE E-MAILED - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Jan 1, 2024ABN6ABANDONMENT - NO USE STATEMENT FILEDThe intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window.
Apr 13, 2023EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 12, 2023EX5GSOU EXTENSION 5 GRANTED
Apr 10, 2023AITUCASE ASSIGNED TO INTENT TO USE PARALEGAL
Apr 4, 2023EXT5SOU EXTENSION 5 FILED
Apr 4, 2023EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 23, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Nov 21, 2022EX4GSOU EXTENSION 4 GRANTED
Nov 21, 2022EXT4SOU EXTENSION 4 FILED
Nov 21, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Nov 16, 2022TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Nov 16, 2022ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Nov 16, 2022REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jun 3, 2022EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Jun 1, 2022EX3GSOU EXTENSION 3 GRANTED
Jun 1, 2022EXT3SOU EXTENSION 3 FILED
Jun 1, 2022EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Oct 28, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 26, 2021EX2GSOU EXTENSION 2 GRANTED
Oct 26, 2021EXT2SOU EXTENSION 2 FILED
Oct 26, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
May 27, 2021EXRANOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 25, 2021EX1GSOU EXTENSION 1 GRANTED
May 25, 2021EXT1SOU EXTENSION 1 FILED
May 25, 2021EEXTSOU TEAS EXTENSION RECEIVEDThe applicant requested more time to file a Statement of Use before the Notice of Allowance deadline. Each extension typically adds six months. A limited number of extensions are available for intent-to-use applications not yet in use.
Jan 7, 2021CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jan 7, 2021TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED
Jan 7, 2021EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Jan 7, 2021ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 7, 2021REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Jan 7, 2021COARTEAS CHANGE OF OWNER ADDRESS RECEIVED
Dec 1, 2020NOAMNOA E-MAILED - SOU REQUIRED FROM APPLICANTA Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date.
Oct 6, 2020NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Oct 6, 2020PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Sep 16, 2020NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Sep 3, 2020CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER
Aug 15, 2020TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Aug 15, 2020CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Aug 12, 2020ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED
Feb 21, 2020GNS2NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED
Feb 21, 2020GNSIINQUIRY TO SUSPENSION E-MAILED
Feb 21, 2020CNSISUSPENSION INQUIRY WRITTEN
Jan 31, 2020RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Jul 11, 2019RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Dec 16, 2018GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Dec 16, 2018GNSLLETTER OF SUSPENSION E-MAILED
Dec 16, 2018CNSLSUSPENSION LETTER WRITTEN
Nov 20, 2018TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Nov 19, 2018CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Nov 19, 2018TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 5, 2018GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2018GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Jun 5, 2018CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Apr 17, 2018RCCKSUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Oct 11, 2017RCSCREPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Oct 9, 2017ALIEASSIGNED TO LIE
Mar 27, 2017GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Mar 27, 2017GNSLLETTER OF SUSPENSION E-MAILED
Mar 27, 2017CNSLSUSPENSION LETTER WRITTEN
Mar 23, 2017TEMETEAS/EMAIL CORRESPONDENCE ENTERED
Mar 23, 2017CRFACORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 23, 2017TROATEAS RESPONSE TO OFFICE ACTION RECEIVEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jan 11, 2017ASCKASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
Dec 16, 2016ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 16, 2016REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Dec 7, 2016ASGNAUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
Sep 28, 2016GNRNNOTIFICATION OF NON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2016GNRTNON-FINAL ACTION E-MAILEDA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2016CNRTNON-FINAL ACTION WRITTENA non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application.
Sep 28, 2016DOCKASSIGNED TO EXAMINER
Jun 27, 2016NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Jun 24, 2016NWAPNEW APPLICATION ENTERED

Frequently asked questions

Related guidance